Cancer Family
Glandular Cell Neoplasm
CI-CAN-00000188Explore in graph →
Non-malignant2,825 active trials43 approved drugs426 evidence items
- NCIt
- C7132
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000188Explore in graph →
Clinical trials
10,211 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01318200 | Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) | withdrawn | Phase 3 | 0 | Accuray IncorporatedINDUSTRY | 1 | Feb 20, 2012 | clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00913198 |
| A Study of CP-4126 in Patients With Advanced Pancreatic Cancer |
| completed |
| Phase 2 |
| 21 |
| Clavis PharmaINDUSTRY |
| 2 |
| Feb 10, 2012 |
| clinicaltrials |
| NCT01088581 | Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma | completed | Phase 3 | 101 | Yonsei UniversityOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01131689 | Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 20 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01372189 | Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy | completed | — | 40 | Shandong UniversityOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01510002 | Prophylactic Central Neck Dissection for Papillary Thyroid Cancer | completed | N/A | 640 | Jagiellonian UniversityOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00561912 | Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 26, 2011 | clinicaltrials |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Dec 20, 2011 | clinicaltrials |
| NCT01355107 | Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease | completed | — | 32 | University Hospital FreiburgOTHER | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 3 | 300 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01100489 | Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT01478412 | An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer(Clarity) | unknown | — | 20 | John Chang, MDOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | terminated | Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT01484704 | The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer | unknown | — | 100 | Turku University HospitalOTHER_GOV | 1 | Dec 2, 2011 | clinicaltrials |
| NCT01482585 | Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy | unknown | — | 200 | Samsung Medical CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00197860 | Dendritic Cell Based Therapy of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 40 | Inge Marie SvaneOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00298545 | Effect of Vitamin D and Calcium on Genes in the Colon | completed | Phase 1 | 10 | Rockefeller UniversityOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT01276769 | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer | unknown | Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT01245582 | Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients(SECOX) | withdrawn | Phase 3 | 0 | SanofiINDUSTRY | 0 | Nov 9, 2011 | clinicaltrials |
| NCT00927043 | Study Evaluating Renal Cell Carcinoma Risk Factors(MICRA) | completed | — | 145 | PfizerINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT01246843 | Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib | completed | — | 50 | Radboud University Medical CenterOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT01173445 | Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma | completed | — | 19 | University of KansasOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036036 | Study of CP-461 in Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 14 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00519688 | UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | completed | Phase 2 | 44 | National Taiwan University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00225290 | Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve | terminated | Phase 3 | 230 | TTY BiopharmINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00427817 | PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma | completed | — | 300 | University Hospital, GrenobleOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT00563147 | A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma | completed | Phase 1 | 28 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 4, 2011 | clinicaltrials |
| NCT01133041 | Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps | completed | Phase 4 | 142 | Soon Chun Hyang UniversityOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01441453 | Transient Elastography in Hepatectomy for Hepatocellular Carcinoma | unknown | N/A | 120 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01387061 | Resection for Multiple Hepatocellular Carcinomas (HCC) | completed | N/A | 87 | University of MilanOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00777504 | Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors | unknown | Phase 4 | 30 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT01429961 | Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 38 | Seoul National University HospitalOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00267748 | Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) | completed | Phase 2 | 317 | PfizerINDUSTRY | 1 | Sep 5, 2011 | clinicaltrials |
| NCT01427101 | Results of CRS and Debulking in PMP Patients | unknown | — | — | Uppsala UniversityOTHER | 0 | Sep 1, 2011 | clinicaltrials |
| NCT00113529 | Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 42 | PfizerINDUSTRY | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00478114 | Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) | completed | Phase 3 | 15 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00703365 | Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 45 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00732745 | Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction | terminated | Phase 1 | 9 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00655252 | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 19, 2011 | clinicaltrials |
| NCT01417442 | BRAF V600E Mutations In Papillary Thyroid Carcinoma | unknown | Early Phase 1 | 150 | Bezmialem Vakif UniversityOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT01415063 | Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma | unknown | Phase 4 | 120 | Sun Yat-sen UniversityOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00444314 | Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 82 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00287222 | Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 21 | University of ArkansasOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2012source: clinicaltrials